tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Evolus announces Evolysse Sculpt trial meets primary endpoint
PremiumThe FlyEvolus announces Evolysse Sculpt trial meets primary endpoint
2M ago
Evolus submits Evolysse premarket approval application to FDA
Premium
The Fly
Evolus submits Evolysse premarket approval application to FDA
2M ago
Evolus, Inc. Advances Safety Study of NUCEIVA for Glabellar Lines
Premium
Company Announcements
Evolus, Inc. Advances Safety Study of NUCEIVA for Glabellar Lines
3M ago
Evolus price target lowered to $18 from $21 at BTIG
PremiumThe FlyEvolus price target lowered to $18 from $21 at BTIG
3M ago
Evolus cut to Hold at Needham after ‘significant’ Jeuveau downturn
Premium
The Fly
Evolus cut to Hold at Needham after ‘significant’ Jeuveau downturn
3M ago
Evolus downgraded to Hold from Buy at Needham
Premium
The Fly
Evolus downgraded to Hold from Buy at Needham
3M ago
Evolus sees FY25 revenue $295M-$305M, consensus $348.2M
PremiumThe FlyEvolus sees FY25 revenue $295M-$305M, consensus $348.2M
3M ago
Evolus down 25% at $6.66 after Q2 earnings miss
Premium
The Fly
Evolus down 25% at $6.66 after Q2 earnings miss
3M ago
Evolus, Inc. Advances NUCEIVA Safety Study: Key Insights for Investors
Premium
Company Announcements
Evolus, Inc. Advances NUCEIVA Safety Study: Key Insights for Investors
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100